Related Articles
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant
Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy
FACTORS MODIFYING THE RISK OF ACUTE AND CONDITIONED NAUSEA AND VOMITING IN OVARIAN-CANCER PATIENTS
Survey of chemotherapy‑induced nausea and vomiting in patients with urothelial carcinoma